These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 28273561)
1. Ferrocene-embedded flavonoids targeting the Achilles heel of multidrug-resistant cancer cells through collateral sensitivity. Pérès B; Nasr R; Zarioh M; Lecerf-Schmidt F; Di Pietro A; Baubichon-Cortay H; Boumendjel A Eur J Med Chem; 2017 Apr; 130():346-353. PubMed ID: 28273561 [TBL] [Abstract][Full Text] [Related]
2. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux. Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445 [TBL] [Abstract][Full Text] [Related]
3. MRP1-dependent Collateral Sensitivity of Multidrug-resistant Cancer Cells: Identifying Selective Modulators Inducing Cellular Glutathione Depletion. Lorendeau D; Dury L; Nasr R; Boumendjel A; Teodori E; Gutschow M; Falson P; Di Pietro A; Baubichon-Cortay H Curr Med Chem; 2017; 24(12):1186-1213. PubMed ID: 27855620 [TBL] [Abstract][Full Text] [Related]
4. Flavonoid dimers are highly potent killers of multidrug resistant cancer cells overexpressing MRP1. Dury L; Nasr R; Lorendeau D; Comsa E; Wong I; Zhu X; Chan KF; Chan TH; Chow L; Falson P; Di Pietro A; Baubichon-Cortay H Biochem Pharmacol; 2017 Jan; 124():10-18. PubMed ID: 27984000 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells. Reiter C; Capcı Karagöz A; Fröhlich T; Klein V; Zeino M; Viertel K; Held J; Mordmüller B; Emirdağ Öztürk S; Anıl H; Efferth T; Tsogoeva SB Eur J Med Chem; 2014 Mar; 75():403-12. PubMed ID: 24561670 [TBL] [Abstract][Full Text] [Related]
6. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. van Zanden JJ; Geraets L; Wortelboer HM; van Bladeren PJ; Rietjens IM; Cnubben NH Biochem Pharmacol; 2004 Apr; 67(8):1607-17. PubMed ID: 15041478 [TBL] [Abstract][Full Text] [Related]
7. 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity. Rocha Gda G; Oliveira RR; Kaplan MA; Gattass CR Eur J Pharmacol; 2014 Oct; 741():140-9. PubMed ID: 25111243 [TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1. de Jong MC; Scheffer GL; Broxterman HJ; Hooijberg JH; Slootstra JW; Meloen RH; Kreitman RJ; Husain SR; Joshi BH; Puri RK; Scheper RJ Clin Cancer Res; 2003 Oct; 9(13):5009-17. PubMed ID: 14581376 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and modes of action of 4'-hydroxy-2',6'-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines. Kuete V; Nkuete AH; Mbaveng AT; Wiench B; Wabo HK; Tane P; Efferth T Phytomedicine; 2014 Oct; 21(12):1651-7. PubMed ID: 25442273 [TBL] [Abstract][Full Text] [Related]
10. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells. Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of three naturally occurring flavonoid derived compounds (artocarpesin, cycloartocarpesin and isobavachalcone) towards multi-factorial drug-resistant cancer cells. Kuete V; Mbaveng AT; Zeino M; Fozing CD; Ngameni B; Kapche GD; Ngadjui BT; Efferth T Phytomedicine; 2015 Nov; 22(12):1096-102. PubMed ID: 26547532 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance. Pape VF; Tóth S; Füredi A; Szebényi K; Lovrics A; Szabó P; Wiese M; Szakács G Eur J Med Chem; 2016 Jul; 117():335-54. PubMed ID: 27161177 [TBL] [Abstract][Full Text] [Related]
13. Ferrocene-cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel. Podolski-Renić A; Bősze S; Dinić J; Kocsis L; Hudecz F; Csámpai A; Pešić M Metallomics; 2017 Aug; 9(8):1132-1141. PubMed ID: 28737782 [TBL] [Abstract][Full Text] [Related]
14. Identification of xanthones as selective killers of cancer cells overexpressing the ABC transporter MRP1. Genoux-Bastide E; Lorendeau D; Nicolle E; Yahiaoui S; Magnard S; Di Pietro A; Baubichon-Cortay H; Boumendjel A ChemMedChem; 2011 Aug; 6(8):1478-84. PubMed ID: 21634011 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer. Yuan Y; Cai T; Xia X; Zhang R; Chiba P; Cai Y Drug Deliv; 2016 Nov; 23(9):3350-3357. PubMed ID: 27098896 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines. Kuete V; Sandjo LP; Ouete JL; Fouotsa H; Wiench B; Efferth T Phytomedicine; 2014 Feb; 21(3):315-22. PubMed ID: 24075210 [TBL] [Abstract][Full Text] [Related]
17. Flavonostilbenes from Sophora alopecuroides L. as multidrug resistance associated protein 1 (MRP1) inhibitors. Ni K; Yang L; Wan C; Xia Y; Kong L Nat Prod Res; 2014; 28(23):2195-8. PubMed ID: 24956120 [TBL] [Abstract][Full Text] [Related]
18. Exocyclic Sulfur and Selenoorganic Compounds Towards Their Anticancer Effects: Crystallographic and Biological Studies. Żesławska E; Kincses A; Unger V; Tóth V; Spengler G; Nitek W; Tejchman W Anticancer Res; 2018 Aug; 38(8):4577-4584. PubMed ID: 30061224 [TBL] [Abstract][Full Text] [Related]